CRISPR Teams Up With Massachusetts General Hospital on Gene-editing Immunotherapies – Immuno-Oncology News
Immuno-Oncology News |
CRISPR Teams Up With Massachusetts General Hospital on Gene-editing Immunotherapies
Immuno-Oncology News Researchers at CRISPR Therapeutics and Massachusetts General Hospital Cancer Center have joined forces to develop T-cell-based cancer immunotherapies using the CRISPR/Cas9 gene editing system. CRISPR/Cas9 allows researchers to alter or silence genes in … |
